Cochlear Ltd
OTC:CHEOF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cochlear Ltd
OTC:CHEOF
|
AU |
|
Almadex Minerals Ltd
XTSX:DEX
|
CA |
|
IGEA Pharma NV
F:3B5
|
NL |
|
Haitong International Securities Group Ltd
HKEX:665
|
HK |
|
D
|
DIH Holding US Inc
NASDAQ:DHAI
|
US |
|
Y
|
Yuan Jen Enterprises Co Ltd
TWSE:1725
|
TW |
|
Mistral Iberia Real Estate Socimi SA
MAD:YMIB
|
ES |
Wall Street
Price Targets
CHEOF Price Targets Summary
Cochlear Ltd
According to Wall Street analysts, the average 1-year price target for
CHEOF
is 184.93 USD
with a low forecast of 141.94 USD and a high forecast of 236.26 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CHEOF's stock price target?
Price Target
184.93
USD
According to Wall Street analysts, the average 1-year price target for
CHEOF
is 184.93 USD
with a low forecast of 141.94 USD and a high forecast of 236.26 USD.
What is Cochlear Ltd's Revenue forecast?
Projected CAGR
8%
For the last 13 years the
compound annual growth rate for
Cochlear Ltd's revenue is
9%.
The projected
CAGR
for the next 3 years is
8%.
What is Cochlear Ltd's Operating Income forecast?
Projected CAGR
10%
For the last 13 years the
compound annual growth rate for
Cochlear Ltd's operating income is
7%.
The projected
CAGR
for the next 3 years is
10%.
What is Cochlear Ltd's Net Income forecast?
Projected CAGR
10%
For the last 13 years the
compound annual growth rate for
Cochlear Ltd's net income is
16%.
The projected
CAGR
for the next 3 years is
10%.
